CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Rigel Pharmaceuticals GAAP EPS of $0.88 beats by $0.11, revenue of $78.7M beats by $23.43M

EarningsPositive
AI Analysis

Summary

Rigel Pharmaceuticals reported Q2 2026 GAAP EPS of $0.88, beating estimates by $0.11, and revenue of $78.7M, exceeding expectations by $23.43M.

Financial Highlights

Revenue

$78.7M

EPS

$0.88

Importance:5/10
Sentiment:
0.70
earningsbeatrevenueEPS
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 4, 2026 8:27 PM

Read Original